|
JP4118958B2
(ja)
|
1996-10-09 |
2008-07-16 |
ファーマセット，リミティド |
テトラホスホネート二環式トリス無水物
|
|
DK0981534T3
(da)
|
1997-02-06 |
2006-09-04 |
Inspire Pharmaceuticals Inc |
Dinukleotider og deres anvendelser
|
|
US7223744B2
(en)
|
1997-02-10 |
2007-05-29 |
Inspire Pharmaceuticals, Inc. |
Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
|
|
US20040181078A1
(en)
*
|
1997-10-10 |
2004-09-16 |
Pharmasset, Ltd. |
Tetraphosphonate bicyclic trisanhydrides
|
|
DE60028253T2
(de)
*
|
1999-12-17 |
2007-03-08 |
Ariad Pharmaceuticals, Inc., Cambridge |
Neue purine
|
|
CA2394654A1
(en)
|
1999-12-17 |
2001-06-21 |
Manfred Weigele |
Proton pump inhibitors
|
|
US6787526B1
(en)
|
2000-05-26 |
2004-09-07 |
Idenix Pharmaceuticals, Inc. |
Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
|
|
US6875751B2
(en)
|
2000-06-15 |
2005-04-05 |
Idenix Pharmaceuticals, Inc. |
3′-prodrugs of 2′-deoxy-β-L-nucleosides
|
|
US6867199B2
(en)
|
2000-08-21 |
2005-03-15 |
Inspire Pharmaceuticals, Inc. |
Dinucleoside polyphosphate compositions and their therapeutic use
|
|
US6555675B2
(en)
|
2000-08-21 |
2003-04-29 |
Inspire Pharmaceuticals, Inc. |
Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists
|
|
WO2002048165A2
(en)
*
|
2000-12-15 |
2002-06-20 |
Pharmasset Ltd. |
Antiviral agents for treatment of flaviviridae infections
|
|
MXPA05011296A
(es)
|
2003-04-25 |
2006-01-24 |
Gilead Sciences Inc |
Conjugados de fosfonato inhibidores de la cinasa.
|
|
US7300924B2
(en)
|
2003-04-25 |
2007-11-27 |
Gilead Sciences, Inc. |
Anti-infective phosphonate analogs
|
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
|
WO2004096287A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
|
EP2359833A1
(en)
|
2003-04-25 |
2011-08-24 |
Gilead Sciences, Inc. |
Antiviral phosphonate analogs
|
|
EP2345657A1
(en)
|
2003-05-30 |
2011-07-20 |
Pharmasset, Inc. |
Modified fluorinated nucleoside analogues
|
|
WO2005044308A1
(en)
|
2003-10-24 |
2005-05-19 |
Gilead Sciences, Inc. |
Phosphonate analogs of antimetabolites
|
|
US7427624B2
(en)
|
2003-10-24 |
2008-09-23 |
Gilead Sciences, Inc. |
Purine nucleoside phosphorylase inhibitory phosphonate compounds
|
|
WO2005063751A1
(en)
|
2003-12-22 |
2005-07-14 |
Gilead Sciences, Inc. |
4’-substituted carbovir-and abacavir-derivatives as well as related compounds with hiv and hcv antiviral activity
|
|
DE10361932A1
(de)
*
|
2003-12-30 |
2005-07-28 |
Celanese Ventures Gmbh |
Protonenleitende Membran und deren Verwendung
|
|
DE10361832A1
(de)
*
|
2003-12-30 |
2005-07-28 |
Celanese Ventures Gmbh |
Protonenleitende Membran und deren Verwendung
|
|
ME03423B
(me)
|
2004-07-27 |
2020-01-20 |
Gilead Sciences Inc |
Fosfonatni analozi jedinjenja hiv inhibitora
|
|
EP1933848A2
(en)
*
|
2005-10-06 |
2008-06-25 |
Innate Pharma |
Phosphoantigen salts of organic bases and methods for their crystallization
|
|
US20090111774A1
(en)
*
|
2007-06-01 |
2009-04-30 |
Luitpold Pharmaceuticals, Inc. |
Pmea lipid conjugates
|
|
CA2714198A1
(en)
*
|
2008-02-15 |
2009-08-20 |
Microdose Therapeutx, Inc. |
Methods of making nucleoside tetraphosphate analogs
|
|
UA103329C2
(ru)
|
2008-07-08 |
2013-10-10 |
Гилиад Сайенсиз, Инк. |
Соли соединений-ингибиторов вич
|
|
EP2358398A2
(en)
|
2008-10-24 |
2011-08-24 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and methods
|
|
KR101869570B1
(ko)
|
2010-04-28 |
2018-06-20 |
아이오니스 파마수티컬즈, 인코포레이티드 |
변형된 뉴클레오사이드 및 그로부터 제조된 올리고머 화합물
|
|
WO2011139699A2
(en)
|
2010-04-28 |
2011-11-10 |
Isis Pharmaceuticals, Inc. |
5' modified nucleosides and oligomeric compounds prepared therefrom
|
|
US9156873B2
(en)
|
2010-04-28 |
2015-10-13 |
Isis Pharmaceuticals, Inc. |
Modified 5′ diphosphate nucleosides and oligomeric compounds prepared therefrom
|
|
CN105073768A
(zh)
*
|
2013-03-13 |
2015-11-18 |
达纳-法伯癌症研究所股份有限公司 |
Ras抑制剂及其用途
|
|
HUE063388T2
(hu)
*
|
2016-01-08 |
2024-01-28 |
Arcus Biosciences Inc |
Ekto-5'-nukleotidáz modulátorok és ezek alkalmazása
|
|
EP3541396A4
(en)
*
|
2016-11-18 |
2020-07-22 |
Arcus Biosciences, Inc. |
CD73-MEDIATED IMMUNOSUPPRESSION INHIBITORS
|
|
SI3661937T1
(sl)
|
2017-08-01 |
2021-11-30 |
Gilead Sciences, Inc. |
Kristalinične oblike etil((S)-((((2R,5R)-5-(6-amino-9H-purin-9-IL)-4- fluoro-2,5-dihidrofuran-2-IL)oksi)metil)(fenoksi)fosforil)-L-alaninata (GS-9131) za zdravljenje virusnih okužb
|
|
WO2020210970A1
(en)
*
|
2019-04-16 |
2020-10-22 |
Bioardis Llc |
Imidazotriazine derivatives as cd73 inhibitors
|
|
US11633416B1
(en)
|
2020-03-06 |
2023-04-25 |
Arcus Biosciences, Inc. |
Oral formulations of CD73 compounds
|